NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Centre for Drug Design and Discovery

Centre for Drug Design and Discovery

Leuvencd3.be

Overview

Centre for Drug Design and Discovery is a Belgium-based investment fund and drug discovery center that invests in and supports the translation of academic and biotech biomedical research into new medicines.

Year Founded

2006

Portfolio Companies

3

Website

cd3.be

Investments

Centre for Drug Design and Discovery investments
CompanyDateStageLead
Endlyz TherapeuticsMay 2026SeedCo-investor
Enedra TherapeuticsMay 2025VC RoundLead
Endlyz TherapeuticsMar 2025SeedCo-investor
Rewind TherapeuticsJan 2023Series A ExtensionCo-investor
Rewind TherapeuticsJan 2018Series ACo-investor

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersLeuven
Year Founded2006

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.